TABLE 2.
Pathological characteristics between patients with urinary 58K(+)/SV40-T(+) cells and those without urinary 58K(+)/SV40-T(+) cells.
| Parameters | With urinary 58K(+)/SV40-T(+) cells (n = 29) | Without urinary 58K(+)/SV40-T(+) cells (n = 47) | P |
| Extent of SV40-T staining (%) | 21.4 ± 11.8 | 12.0 ± 7.5 | <0.001 |
| Pathological Banff scores | |||
| t | 1.8 ± 0.8 | 1.5 ± 0.7 | 0.127 |
| i | 1.1 ± 1.1 | 0.7 ± 0.8 | 0.520 |
| ct | 1.9 ± 0.7 | 1.7 ± 0.8 | 0.429 |
| ci | 1.9 ± 0.7 | 1.7 ± 0.7 | 0.272 |
| BKPyVAN stage (%) | 0.667 | ||
| A | 1 (3.4) | 4 (8.5) | |
| B | 25 (86.2) | 38 (80.9) | |
| C | 3 (10.3) | 5 (10.6) |
58K, 58-kDa Golgi protein; t, tubulitis; i, interstitial inflammation; ct, tubular atrophy; ci, interstitial fibrosis; BKPyVAN, BK polyomavirus associated-nephropathy.